Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 25:16:947240.
doi: 10.3389/fnins.2022.947240. eCollection 2022.

Gut microbes and food reward: From the gut to the brain

Affiliations
Review

Gut microbes and food reward: From the gut to the brain

Alice de Wouters d'Oplinter et al. Front Neurosci. .

Abstract

Inappropriate food intake behavior is one of the main drivers for fat mass development leading to obesity. Importantly the gut microbiota-mediated signals have emerged as key actors regulating food intake acting mainly on the hypothalamus, and thereby controlling hunger or satiety/satiation feelings. However, food intake is also controlled by the hedonic and reward systems leading to food intake based on pleasure (i.e., non-homeostatic control of food intake). This review focus on both the homeostatic and the non-homeostatic controls of food intake and the implication of the gut microbiota on the control of these systems. The gut-brain axis is involved in the communications between the gut microbes and the brain to modulate host food intake behaviors through systemic and nervous pathways. Therefore, here we describe several mediators of the gut-brain axis including gastrointestinal hormones, neurotransmitters, bioactive lipids as well as bacterial metabolites and compounds. The modulation of gut-brain axis by gut microbes is deeply addressed in the context of host food intake with a specific focus on hedonic feeding. Finally, we also discuss possible gut microbiota-based therapeutic approaches that could lead to potential clinical applications to restore food reward alterations. Therapeutic applications to tackle these dysregulations is of utmost importance since most of the available solutions to treat obesity present low success rate.

Keywords: food intake; food reward; gut microbes; gut microbiome; gut-brain-axis; obesity.

PubMed Disclaimer

Conflict of interest statement

PC, AdW, and AE are inventors on patents dealing with the use of gut microbes in the treatment of metabolic disorders. PC is co-founder of A-Mansia biotech SA and Enterosys. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The homeostatic control of food intake upon peripheric signals. Orexigenic hormones or neurotransmitters are in green; anorexigenic hormones or neurotransmitters are in red. PVN: paraventricular nucleus; SIM1, single–minded family BHLH transcription factor 1; LH, lateral hypothalamus; MCH, melanin-concentrating hormone; Arc, arcuate nucleus; AgRP, agouti-related protein; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; CART, cocaine-amphetamine-related transcript; NTS, nucleus tractus solitarus; VAN, vagal afferent nerves; CCK, cholecystokinin; GLP-1, glucagon-like peptide 1; PYY, peptide YY; MC4R, Melanocortin 4 receptor. Created with BioRender.com.
FIGURE 2
FIGURE 2
The reward system controlling non-homeostatic food intake. Nac, nucleus accumbens; GABA, γ-aminobutyric acid; VTA, ventral tegmental area. Created with BioRender.com.
FIGURE 3
FIGURE 3
The role of the gut microbiota in homeostatic and non-homeostatic controls of food intake. Potential links are represented in dashed arrows. Demonstrated links are represented in solid arrows. PVN, paraventricular nucleus; SIM1, single–minded family BHLH transcription factor 1; LH, lateral hypothalamus; Str, striatum; Nac, nucleus accumbens; GABA, γ-aminobutyric acid; PFC, prefrontal cortex; Arc, arcuate nucleus; AgRP, agouti-related protein; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; CART, cocaine-amphetamine-related transcript; NTS, nucleus tractus solitarus; VTA, ventral tegmental area; DA, dopamine; VAN, vagal afferent nerves; CCK, cholecystokinin; GLP-1, glucagon-like peptide 1; PYY, peptide YY; SCFAs, short-chain fatty acids; LPS, lipopolysaccharide; MC4R, Melanocortin 4 receptor. Created with BioRender.com.

Similar articles

Cited by

References

    1. Aarts E., Ederveen T. H. A., Naaijen J., Zwiers M. P., Boekhorst J., Timmerman H. M., et al. (2017). Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One 12:e0183509. 10.1371/journal.pone.0183509 - DOI - PMC - PubMed
    1. Abbott C. R., Monteiro M., Small C. J., Sajedi A., Smith K. L., Parkinson J. R., et al. (2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044 127–131. 10.1016/j.brainres.2005.03.011 - DOI - PubMed
    1. Acuna-Goycolea C., van den Pol A. N. (2005). Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J. Neurosci. 25 10510–10519. 10.1523/JNEUROSCI.2552-05.2005 - DOI - PMC - PubMed
    1. Aguera Z., Lozano-Madrid M., Mallorqui-Bague N., Jimenez-Murcia S., Menchon J. M., Fernandez-Aranda F. (2021). A review of binge eating disorder and obesity. Neuropsychiatr 35 57–67. 10.1007/s40211-020-00346-w - DOI - PubMed
    1. Agusti A., Campillo I., Balzano T., Benitez-Paez A., Lopez-Almela I., Romani-Perez M., et al. (2021). Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat. Mol. Neurobiol. 58 4959–4979. 10.1007/s12035-021-02462-2 - DOI - PMC - PubMed

LinkOut - more resources